Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹325.90down ₹3.15 (0.96%)BSE ₹326.15
Share price at the NSE close on 29 Oct 2026. Previous close ₹329.05.
29 Oct: open ₹329.00, high ₹331.70, low ₹323.05
52-week range of traded prices to 29 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,996 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.39
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 25,41247.9% delivered
Panacea Biotec board meetings
135 filed, newest first. Page 3 of 3.
Oct 2013
30 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter and half year ended September 30, 2013.
Jul 2013
25 Jul · Board meeting
To interalia, consider and approve the Unaudited Financial Results (Provisional) for the quarter ended June 30, 2013.
Jun 2013
4 Jun · Board meeting
Vide letter dated May 30, 2013 that the Board of Directors of the Company at its meeting held on May 30, 2013, has not recommended any dividend on the Equity Shares of the Company for the financial year ended March 31, 2013 in view of non-availability of profits.
May 2013
10 May · Board meeting
To inter-alia, consider and approve the Audited Financial Results for the Financial Year 2012-13.
Jan 2013
2 Jan · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2012.
Oct 2012
16 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter and half year ended September 30, 2012.
Jul 2012
12 Jul · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter ended June 30, 2012.
May 2012
19 May · Board meeting
In view of non-availability of profits, the Board of Directors at its meeting held on May 18, 2012 has not recommended any dividend on the Equity Shares of the Company for the financial year ended on March 31, 2012.
Apr 2012
27 Apr · Board meeting
Inter alia, to consider and approve the Audited Financial Results for the Financial Year 2011-12 and the matter pertaining to recommendation / passing over of dividend.
Jan 2012
19 Jan · Board meeting
To inter-alia consider and approve the Unaudited Financial Results (provisional) for the quarter and nine months ended December 31, 2011.
Oct 2011
10 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter and half-year ended September 30, 2011.
Jul 2011
11 Jul · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter ended June 30, 2011.
May 2011
3 May · Board meeting
To inter-alia, consider and approve the Audited Financial Results for the Financial Year 2010-11 and to recommend dividend, if any, on the share capital of the Company.
Jan 2011
17 Jan · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter as well as nine months ended December 31, 2010.
Oct 2010
19 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter and half-year ended September 30, 2010.
Jul 2010
12 Jul · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter ended June 30, 2010.
Apr 2010
29 Apr · Board meeting
To inter-alia, consider and approve the Audited Financial Results for the Financial year 2009-10 and to recommend dividend, if any, on the share capital of the Company.
Jan 2010
21 Jan · Board meeting
Panacea Biotec Ltd. has informed the Exchange regarding the outcome of Board Meeting held on January 21, 2010 to review & reconsider the terms of proposed Buyback of Equity shares. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jan · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter as well as nine months ended December 31, 2009.18 Jan · Board meeting
To inter-alia, consider and approve the revised terms & conditions of the proposed buy-back of its Equity Shares. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2009
24 Dec · Board meeting
To inter-alia, consider and approve the buy-back of its Equity Shares pursuant to the applicable provisions of Companies Act, 1956 and SEBI (Buy-back of Securities) Regulations 1998.
Oct 2009
20 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter as well as half-year ended September 30, 2009.
Jul 2009
15 Jul · Board meeting
To inter-alia, consider and take on record the Unaudited Financial Results (Provisional) for the quarter ended June 30, 2009.
May 2009
19 May · Board meeting
To inter-alia, consider and approve the Audited Financial Results for the Financial Year 2008-2009.
Jan 2009
13 Jan · Board meeting
Meeting on 29 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
17 Oct · Board meeting
Company had informed the Exchange that a Meeting of the Board of Directors of the Company will be held on October 17, 2008, to inter-alia, consider and take on record the Unaudited Financial Results (Provisional) for the quarter as well as half-year ended September 30, 2008. The Company has now informed the Exchange that due to non-availability of quorum the Board meeting of the Company could not be held on October 17, 2008 and will now be held on October 31, 2008.
Sep 2008
18 Sep · Board meeting
To inter-alia, consider and take on record the Unaudited Financial Results (Provisional) for the quarter as well as half-year ended September 30, 2008.
Jul 2008
14 Jul · Board meeting
Meeting on 28 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Jun 2008
11 Jun · Board meeting
To inter-alia, consider and approve the Audited Financial Results for the Financial Year 2007-08 and to recommend dividend, if any, on the Share Capital of the Company.
Jan 2008
10 Jan · Board meeting
Company had informed the Exchange regarding a Board Meeting scheduled to be held on January 23, 2008, to inter-alia, consider and take on record the Unaudited Financial Results (Provisional) for the quarter as well as nine months ended December 31, 2007. The Company has now informed the Exchange that inadvertently the date of Board Meeting was mentioned as January 23, 2008 instead of January 24, 2008. The meeting of the Board of Directors will be held on January 24, 2008.3 Jan · Board meeting
Meeting on 23 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Oct 2007
9 Oct · Board meeting
To inter-alia, consider and take on record the Unaudited Financial Results (Provisional) for the quarter as well as half-year ended September 30, 2007.
Jul 2007
12 Jul · Board meeting
Meeting on 24 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
May 2007
31 May · Board meeting
To interalia, consider and approve the Audited Financial Results for the Financial year 2006-2007 and to recommend dividend, if any, on the Share Capital of the Company.
Jan 2007
3 Jan · Board meeting
To inter-alia, consider and take on record the Unaudited Financial Results (Provisional) for the quarter and nine months ended 31st December, 2006.